InvestorsHub Logo

BIOChecker4

11/16/21 4:12 PM

#336163 RE: georgejjl #336152

Wishful thinking. Nothing more.

nidan7500

11/16/21 4:46 PM

#336167 RE: georgejjl #336152

Thanks georgejji. It's helpful to see this summary of facts.

Catalysts to Drive Value

The company has multiple clinical milestones

> Top-line data AVATAR: Potentially pivotal Phase 2/3 adult RTT clinical trial – expected 2H 2021

> Top-line data Phase 1 ANAVEX®3-71 clinical trial – expected 2H 2021

>Top-line data EXCELLENCE: Potentially pivotal Phase 2/3 pediatric RTT clinical trial – expected 1H 2022

>Top-line data ANAVEX®2-73-AD-004: Potentially pivotal Phase 2b/3 AD clinical trial – expected 2H 2022

>Initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical trial – expected 2021

>Pipeline expansion opportunities for ANAVEX®2-73

>Initiation of potentially pivotal Phase 2/3 Fragile X clinical trial – expected 2021

>Initiation of potentially pivotal Phase 2/3 clinical trial for the treatment of a new, rare disease
indication – expected 2021

blue finch

11/16/21 4:51 PM

#336168 RE: georgejjl #336152

Are we going to see earth shattering news tomorrow
Or how about
Are we going to see a press release of any sort tomorrow?



Best of luck to all here

kund

11/16/21 5:57 PM

#336176 RE: georgejjl #336152

Come 2025 catalyst will be same, just change the year on it..LOL